Results 221 to 230 of about 238,870 (356)
Human Cyclophilins—An Emerging Class of Drug Targets
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova +3 more
wiley +1 more source
Endometrial cancer: from clinical reality to molecular treatment. [PDF]
Renaud LI +5 more
europepmc +1 more source
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis
Xieyan Yu, Xiaoxing Zhang
openalex +2 more sources
Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer
ABSTRACT Diverse extracellular vesicles (EVs) are present in all body fluids; however, knowledge of large EVs (lEVs) remains limited. Molecular EV profiles vary depending on EV size and the physiological circulatory system, even within the same patient. In this study, we aimed to characterize the proteomic profile of IEVs in ovarian cancer patients and
Kazuhiro Suzuki +6 more
wiley +1 more source
Predicted peptide scaffolds for drug screening in endometrial cancer organoids. [PDF]
Zhang M, Wan Y, Li D.
europepmc +1 more source
Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez +8 more
wiley +1 more source
Endometrial Cancer in Young Women: Insights From a Tunisian Cohort. [PDF]
Kouira M +7 more
europepmc +1 more source
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations. [PDF]
Cohn, David E +8 more
core +1 more source

